公司资料
scPharmaceuticals 股价、新闻与催化剂
- 股票代码:
- SCPH
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for SCPH.
公司概览
业务概览
scPharmaceuticals is a specialty pharma company focused on drug delivery and outpatient therapy for chronic conditions. Its commercial story is tied to improving how established therapies are delivered in lower-acuity settings.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, scPharmaceuticals sits in specialty biopharma.
商业模式特征
The business depends on product launch execution, patient access, and the broader adoption of convenient outpatient therapy.
生物医药行业定位
scPharmaceuticals is a commercial specialty-pharma name whose stock moves on launch adoption and execution.
未来催化剂
- scPharmaceuticals’ next catalysts are Furoscix adoption and any commercialization step that expands the subcutaneous diuretic franchise. Investors will care about whether the product is becoming a more routine tool in heart-failure management.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。